Tasneem Dohadwala

improving care for patients with heart failure

Diesel Labs delivers novel solutions in support of consumer and content intelligence. From synthetic focus group technology to bespoke curated data, augment traditional market research tools and bring real-time insight to your fingertips. Diesels proprietary technology stack leverages machine learning and generative AI to produce and contextualize intelligence on any topic or group. The hard part is done: data from across all the major social and video platforms is curated, organized and analyzed, ready for seamless integration into business intelligence tools and generative AI models alike. The data illuminates everything from what topics are trending and why to which pieces of media content are capturing audience attention.

Conformal Medical, Inc. is a medical device company developing devices to prevent stroke in patients with non-valvular atrial fibrillation. The company’s proprietary technology will help left atrial appendage closure meet its true potential.

Lantos Technologies is the home of the MIT-developed, proprietary membrane-based, 3D ear scanning technology. We are a team that is dedicated to delivering the best practice in standard of hearing care to hearing professionals, their practices, and their patients.

Augmenix, Inc. is a privately held medical device company focused on the development and commercialization of radiation oncology and urology products using its proprietary hydrogel technology. The company is using this technology to develop products that decrease unintended radiation damage to normal organs during cancer radiation therapy and to mark soft tissue. The SpaceOAR System (OAR stands for “organ at risk”) is an absorbable hydrogel that temporarily moves the rectum away from the prostate and the high intensity radiation zone, protecting the rectum in men undergoing radiation therapy for prostate cancer. Clinically proven, the created space reduces rectal radiation injury and the resulting long term complications. It is the first and only prostate cancer spacing device to receive Food and Drug Administration (FDA) clearance. Additionally, Augmenix has developed an absorbable tissue marker that marks soft tissue for a surgical procedure or future surgical procedures. TraceIT Tissue Marker is visible on multi-modality imaging allowing for improved tissue marking. This technology, licensed from Incept, LLC, comes from a line of products that have made a meaningful impact in the areas of neurosurgery and interventional cardiology. Augmenix is bringing this technology to the field of radiation oncology through high quality investors and an experienced management team. Augmenix, SpaceOAR, and SpaceOAR logo are registered trademarks of Augmenix, Inc.

improving care for patients with heart failure

Diesel Labs delivers novel solutions in support of consumer and content intelligence. From synthetic focus group technology to bespoke curated data, augment traditional market research tools and bring real-time insight to your fingertips. Diesels proprietary technology stack leverages machine learning and generative AI to produce and contextualize intelligence on any topic or group. The hard part is done: data from across all the major social and video platforms is curated, organized and analyzed, ready for seamless integration into business intelligence tools and generative AI models alike. The data illuminates everything from what topics are trending and why to which pieces of media content are capturing audience attention.

Golden Seeds is an investment firm dedicated to pursuing market returns through the empowerment of women entrepreneurs and the people who invest in them. The group was founded in 2005 and is headquartered in New York City, with active chapters in Arizona, Atlanta, Boston, Dallas, Houston, New Jersey, and Silicon Valley – and active members throughout the country. Golden Seeds’ Angel Network has grown to become one of the largest in the country with around 280 members nationwide. Since 2005, over 3200 companies have applied to Golden Seeds for funding. All companies are evaluated, many proceed through due diligence and receive extensive guidance from Golden Seeds investors. In total, Golden Seeds has invested over $170 million in nearly 235 companies through its angel network and its venture funds. Moreover, the firm and its investors have provided important leadership in this investment sector. www.goldenseeds.com

Conformal Medical, Inc. is a medical device company developing devices to prevent stroke in patients with non-valvular atrial fibrillation. The company’s proprietary technology will help left atrial appendage closure meet its true potential.

Lantos Technologies is the home of the MIT-developed, proprietary membrane-based, 3D ear scanning technology. We are a team that is dedicated to delivering the best practice in standard of hearing care to hearing professionals, their practices, and their patients.